Pfizer: A Step-By-Step Strategy Before Earnings
PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...
Nasdaq7d
PFE Factor-Based Stock Analysis
Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to ...
Nasdaq15d
PFE Quantitative Stock Analysis
Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to ...
Hosted on MSN1mon
PFE or NVO: Which Is the Better Value Stock Right Now?
PFE is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. And, based on the above valuation metrics, we feel that PFE is likely the superior value ...
Pfizer (PFE) Advances While Market Declines: Some Information for Investors
Pfizer (PFE) closed the latest trading day at $26.61, indicating a +0.3% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 0.22%. Elsewhere, the ...